Reprint

Advances in Preterm Delivery

Edited by
July 2022
154 pages
  • ISBN978-3-0365-4751-0 (Hardback)
  • ISBN978-3-0365-4752-7 (PDF)

This is a Reprint of the Special Issue Advances in Preterm Delivery that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Preterm delivery (PTD; < 37 weeks’ gestation) complicates 5%–13% of deliveries worldwide, depending on the geographical and demographical characteristics of the population tested. It is the leading cause of perinatal morbidity and mortality, as well as maternal morbidity. In fact, prematurity has both short- and long-term consequences for affected offspring and can leave these individuals with lifelong disabilities, even after the available interventions are attempted. While various risk factors for preterm birth are well-recognized, the etiology for preterm birth is multifactorial. Preterm parturition is a syndrome resulting from the premature activation of the common pathway of parturition, including an increased myometrial contractility; cervical ripening/dilatation and effacement; and membrane/decidual activation. Because the prevalence of preterm birth is so high, it is thought to put more financial, medical, and emotional stress on affected communities than any other perinatal issue. In past years, most of the research interest resulted in the prevention of preterm birth in order to alleviate the complications of prematurity. However, recent evidence suggests that the effect of preterm birth goes beyond the impact on the future health of both the mother and her offspring as well as the specific delivery in which preterm delivery has occurred. This book focuses on the risk factors, perinatal outcomes, and long-term consequences of this critical problem.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
high-risk pregnancy; shortened cervix; microbiome; Lactobacillus; perinatal mortality; preeclampsia; pregnancy complications; preterm birth; preterm delivery; small for gestational age; preterm birth; extreme preterm birth; placental abruption; prematurity; preterm birth; neurological; pediatric; systemic lupus erythematosus; preterm delivery; neurologic morbidity; offspring; preterm labor; high-risk patients; ultrasound; elastography; metalloproteinases; MMP-8; MMP-9; preterm birth; risk factors; prevention; 17-OHPC; micronized progesterone; perinatal outcomes; recommendations; antenatal corticosteroids; betamethasone; preterm infant; mortality; respiratory distress syndrome; prematurity; gestational age; threshold; respiratory morbidity; pediatric hospitalization; Apgar score; neurological morbidities; long-term follow-up; population-based study; retrospective cohort; ophthalmic morbidities; retinopathy of prematurity; gestational age; preterm delivery; n/a

Related Books